Department of Otolaryngology, Boston University Medical Center, Boston, MA 02118, USA.
Dysphagia. 2012 Dec;27(4):538-49. doi: 10.1007/s00455-012-9404-2. Epub 2012 Mar 29.
There is no standardized dysphagia therapy for head and neck cancer patients and scant evidence to support any particular protocol, leaving institutions and individual speech-language pathologists (SLPs) to determine their own protocols based on "typical" practices or anecdotal evidence. To gain an understanding of current usual practices, a national internet-based survey was developed and disseminated to SLPs who treat head and neck cancer (HNC) patients. From a random sample of 4,000 ASHA SID13 members, 1,931 fit the inclusion criteria, and 759 complete responses were recorded for a 39.3 % response rate. Results were analyzed by institution type as well as by individual clinical experience. While some interesting trends emerged from the data, a lack of uniformity and consensus regarding best practices was apparent. This is undoubtedly due to a paucity of research adequately addressing the efficacy of any one therapy for dysphagia in the HNC population.
目前针对头颈部癌症患者尚无标准化的吞咽障碍治疗方法，也几乎没有证据支持任何特定的方案，这使得各机构和个别言语语言病理学家（SLP）只能根据“典型”实践或传闻证据来确定自己的方案。为了了解当前的常规做法，我们开发了一项基于互联网的全国性调查，并分发给治疗头颈部癌症（HNC）患者的 SLP。在 ASHA SID13 成员的随机抽样中，有 1931 名符合纳入标准，记录了 759 名完整回复，回复率为 39.3%。结果按机构类型和个人临床经验进行了分析。虽然数据中出现了一些有趣的趋势，但在最佳实践方面缺乏一致性和共识是显而易见的。这无疑是由于缺乏足够的研究来充分评估任何一种治疗 HNC 人群吞咽障碍的疗法的疗效。
